Improving Power and Accuracy in Randomized Controlled Trials of Pain Treatments by Accounting for Concurrent Analgesic Use.
Pain
low back pain
opioids
outcomes
power
Journal
The journal of pain
ISSN: 1528-8447
Titre abrégé: J Pain
Pays: United States
ID NLM: 100898657
Informations de publication
Date de publication:
02 2023
02 2023
Historique:
received:
30
08
2021
revised:
17
09
2022
accepted:
19
09
2022
pmc-release:
01
02
2024
pubmed:
12
10
2022
medline:
7
2
2023
entrez:
11
10
2022
Statut:
ppublish
Résumé
The 0 to 10 numeric rating scale of pain intensity is a standard outcome in randomized controlled trials (RCTs) of pain treatments. For individuals taking analgesics, there may be a disparity between "observed" pain intensity (pain intensity with concurrent analgesic use) and pain intensity without concurrent analgesic use (what the numeric rating scale would be had analgesics not been taken). Using a contemporary causal inference framework, we compare analytic methods that can potentially account for concurrent analgesic use, first in statistical simulations, and second in analyses of real (non-simulated) data from an RCT of lumbar epidural steroid injections. The default analytic method was ignoring analgesic use, which is the most common approach in pain RCTs. Compared to ignoring analgesic use and other analytic methods, simulations showed that a quantitative pain and analgesia composite outcome based on adding 1.5 points to pain intensity for those who were taking an analgesic (the QPAC
Identifiants
pubmed: 36220482
pii: S1526-5900(22)00417-5
doi: 10.1016/j.jpain.2022.09.017
pmc: PMC9898095
mid: NIHMS1841575
pii:
doi:
Substances chimiques
Analgesics, Opioid
0
Analgesics
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
332-344Subventions
Organisme : NIAMS NIH HHS
ID : P30 AR072572
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002319
Pays : United States
Informations de copyright
Published by Elsevier Inc.
Références
Pharmacoepidemiol Drug Saf. 2015 Dec;24(12):1286-96
pubmed: 26419411
Spine (Phila Pa 1976). 1998 Mar 1;23(5):607-14
pubmed: 9530793
J Gen Intern Med. 2006 Jun;21(6):607-12
pubmed: 16808744
Stat Med. 2008 Oct 30;27(24):5039-53
pubmed: 18613245
Pain Med. 2014 Oct;15(10):1704-14
pubmed: 25087701
Epidemiology. 2009 Jul;20(4):496-9
pubmed: 19525686
Stat Med. 2019 May 20;38(11):2074-2102
pubmed: 30652356
Eur J Pain. 2014 Sep;18(8):1190-8
pubmed: 24577780
Ann Rheum Dis. 2017 Jul;76(7):1269-1278
pubmed: 28153830
JAMA Intern Med. 2016 Jul 1;176(7):958-68
pubmed: 27213267
Stat Med. 1997 Dec 15;16(23):2713-28
pubmed: 9421871
JAMA. 2014 Oct 15;312(15):1507-8
pubmed: 25321905
Nat Commun. 2018 Nov 28;9(1):5052
pubmed: 30487518
Circulation. 2019 Jul 23;140(4):270-279
pubmed: 31234639
N Engl J Med. 2017 Oct 5;377(14):1391-1398
pubmed: 28976864
N Engl J Med. 2014 Jul 3;371(1):11-21
pubmed: 24988555
BMC Musculoskelet Disord. 2022 Apr 21;23(1):376
pubmed: 35449043
PM R. 2021 Mar;13(3):241-249
pubmed: 32902134
Pain. 2018 Nov;159(11):2245-2254
pubmed: 30001225
Epidemiology. 2006 May;17(3):276-84
pubmed: 16617276
Nat Genet. 2009 Jun;41(6):666-76
pubmed: 19430483
Stat Med. 2005 Oct 15;24(19):2911-35
pubmed: 16152135